Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro-carcinogenesis in chronic hepatitis C.
Yamaguchi T, Matsuzaki K, Inokuchi R, Kawamura R, Yoshida K, Murata M, Fujisawa J, Fukushima N, Sata M, Kage M, Nakashima O, Tamori A, Kawada N, Tsuneyama K, Dooley S, Seki T, Okazaki K.
Yamaguchi T, et al.
Hepatol Res. 2013 Dec;43(12):1327-42. doi: 10.1111/hepr.12082. Epub 2013 Mar 4.
Hepatol Res. 2013.
PMID: 23458062